# Teleflex Inc: financial statements, quarterly TFX · NYSE · CIK 96943 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/tfx.md) · [Financials](/companies/tfx/financials.md) · [Filings](/companies/tfx/filings.md) · [Insiders](/companies/tfx/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tfx/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [746](/filings/0000096943-24-000148.md) | [(488) d](/filings/0000096943-26-000019.md) | [413](/filings/0000096943-26-000019.md) | [419](/filings/0000096943-26-000019.md) | [426](/filings/0000096943-26-000019.md) | [442](/filings/0000096943-26-000019.md) | [414](/filings/0000096943-26-000050.md) | [443](/filings/0000096943-26-000095.md) | [567](/filings/0000096943-26-000019.md) | [569](/filings/0000096943-26-000019.md) | [548](/filings/0000096943-26-000050.md) | [570](/filings/0000096943-26-000095.md) | | Cost of revenue | $m | [330](/filings/0000096943-24-000148.md) | [(313) d](/filings/0000096943-26-000019.md) | [322](/filings/0000096943-25-000077.md) | [333](/filings/0000096943-25-000115.md) | [334](/filings/0000096943-25-000138.md) | [(327) d](/filings/0000096943-26-000019.md) | [159](/filings/0000096943-26-000050.md) | [177](/filings/0000096943-26-000095.md) | [461](/filings/0000096943-25-000138.md) | [(250) d](/filings/0000096943-26-000019.md) | [241](/filings/0000096943-26-000050.md) | [239](/filings/0000096943-26-000095.md) | | Gross profit | $m | [416](/filings/0000096943-24-000148.md) | [(175) d](/filings/0000096943-26-000019.md) | [257](/filings/0000096943-26-000019.md) | [252](/filings/0000096943-26-000019.md) | [260](/filings/0000096943-26-000019.md) | [269](/filings/0000096943-26-000019.md) | [255](/filings/0000096943-26-000050.md) | [266](/filings/0000096943-26-000095.md) | [292](/filings/0000096943-26-000019.md) | [307](/filings/0000096943-26-000019.md) | [307](/filings/0000096943-26-000050.md) | [332](/filings/0000096943-26-000095.md) | | Research and development | $m | [37.6](/filings/0000096943-24-000148.md) | [(4.9) d](/filings/0000096943-26-000019.md) | [37.3](/filings/0000096943-25-000077.md) | [41.1](/filings/0000096943-25-000115.md) | [38.7](/filings/0000096943-25-000138.md) | [(8.1) d](/filings/0000096943-26-000019.md) | [25.3](/filings/0000096943-26-000050.md) | [26.5](/filings/0000096943-26-000095.md) | [57.2](/filings/0000096943-25-000138.md) | [12.6 d](/filings/0000096943-26-000019.md) | [44.4](/filings/0000096943-26-000050.md) | [45.1](/filings/0000096943-26-000095.md) | | Selling, general and administrative | $m | [213](/filings/0000096943-24-000148.md) | [(46.5) d](/filings/0000096943-26-000019.md) | [243](/filings/0000096943-25-000077.md) | [251](/filings/0000096943-25-000115.md) | [247](/filings/0000096943-25-000138.md) | [(66.2) d](/filings/0000096943-26-000019.md) | [153](/filings/0000096943-26-000050.md) | [138](/filings/0000096943-26-000095.md) | [282](/filings/0000096943-25-000138.md) | [0.6 d](/filings/0000096943-26-000019.md) | [226](/filings/0000096943-26-000050.md) | [214](/filings/0000096943-26-000095.md) | | Operating income | $m | [165](/filings/0000096943-24-000148.md) | [(165) d](/filings/0000096943-26-000019.md) | [(71.8)](/filings/0000096943-26-000019.md) | [51.1](/filings/0000096943-26-000019.md) | [72.0](/filings/0000096943-26-000019.md) | [52.4](/filings/0000096943-26-000019.md) | [75.8](/filings/0000096943-26-000050.md) | [91.1](/filings/0000096943-26-000095.md) | [(62.4)](/filings/0000096943-26-000019.md) | [13.9](/filings/0000096943-26-000019.md) | [20.2](/filings/0000096943-26-000050.md) | [72.8](/filings/0000096943-26-000095.md) | | Interest expense | $m | [23.2](/filings/0000096943-23-000102.md) | [25.8 d](/filings/0000096943-24-000036.md) | [22.7](/filings/0000096943-24-000072.md) | [21.2](/filings/0000096943-24-000132.md) | [21.1](/filings/0000096943-25-000138.md) | [18.6 d](/filings/0000096943-26-000019.md) | [18.5](/filings/0000096943-26-000050.md) | [21.7](/filings/0000096943-26-000095.md) | [31.8](/filings/0000096943-25-000138.md) | [28.1 d](/filings/0000096943-26-000019.md) | [25.7](/filings/0000096943-26-000050.md) | [28.0](/filings/0000096943-26-000095.md) | | Income tax | $m | [11.9](/filings/0000096943-24-000148.md) | [(5.8) d](/filings/0000096943-26-000019.md) | [(41.6)](/filings/0000096943-25-000077.md) | [17.3](/filings/0000096943-25-000115.md) | [19.6](/filings/0000096943-25-000138.md) | [(26.3) d](/filings/0000096943-26-000019.md) | [6.4](/filings/0000096943-26-000050.md) | [2.5](/filings/0000096943-26-000095.md) | [(29.7)](/filings/0000096943-25-000138.md) | [(30.8) d](/filings/0000096943-26-000019.md) | [1.0](/filings/0000096943-26-000050.md) | [3.4](/filings/0000096943-26-000095.md) | | Net income | $m | [137](/filings/0000096943-24-000148.md) | [31.1 d](/filings/0000096943-26-000019.md) | [15.3](/filings/0000096943-26-000019.md) | [80.0](/filings/0000096943-26-000019.md) | [111](/filings/0000096943-26-000019.md) | [(137)](/filings/0000096943-26-000019.md) | [95.0](/filings/0000096943-26-000095.md) | [123](/filings/0000096943-26-000095.md) | [(409)](/filings/0000096943-26-000019.md) | [(714)](/filings/0000096943-26-000019.md) | [(8.2)](/filings/0000096943-26-000095.md) | [99.7](/filings/0000096943-26-000095.md) | | Diluted EPS | $ per share | [2.90](/filings/0000096943-24-000148.md) | not reported | [0.32](/filings/0000096943-26-000019.md) | [1.69](/filings/0000096943-26-000019.md) | [2.36](/filings/0000096943-26-000019.md) | [(2.93)](/filings/0000096943-26-000019.md) | [2.07](/filings/0000096943-26-000050.md) | [2.77](/filings/0000096943-26-000095.md) | [(9.24)](/filings/0000096943-26-000019.md) | [(16.15)](/filings/0000096943-26-000019.md) | [(0.18)](/filings/0000096943-26-000050.md) | [2.28](/filings/0000096943-26-000095.md) | | Basic EPS | $ per share | [2.92](/filings/0000096943-24-000148.md) | not reported | [0.32](/filings/0000096943-26-000019.md) | [1.70](/filings/0000096943-26-000019.md) | [2.38](/filings/0000096943-26-000019.md) | [(2.95)](/filings/0000096943-26-000019.md) | [2.08](/filings/0000096943-26-000050.md) | [2.77](/filings/0000096943-26-000095.md) | [(9.24)](/filings/0000096943-26-000019.md) | [(16.15)](/filings/0000096943-26-000019.md) | [(0.18)](/filings/0000096943-26-000050.md) | [2.29](/filings/0000096943-26-000095.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [881](/filings/0000096943-23-000102.md) | [223](/filings/0000096943-25-000031.md) | [237](/filings/0000096943-24-000072.md) | [239](/filings/0000096943-24-000132.md) | [243](/filings/0000096943-24-000148.md) | [248](/filings/0000096943-26-000019.md) | [284](/filings/0000096943-25-000077.md) | [254](/filings/0000096943-25-000115.md) | [354](/filings/0000096943-25-000138.md) | [379](/filings/0000096943-26-000095.md) | [309](/filings/0000096943-26-000050.md) | [300](/filings/0000096943-26-000095.md) | | Current assets | $m | [2,097](/filings/0000096943-23-000102.md) | [1,407](/filings/0000096943-25-000031.md) | [1,434](/filings/0000096943-24-000072.md) | [1,438](/filings/0000096943-24-000132.md) | [1,499](/filings/0000096943-24-000148.md) | [1,471](/filings/0000096943-26-000019.md) | [1,539](/filings/0000096943-25-000077.md) | [1,724](/filings/0000096943-25-000115.md) | [1,986](/filings/0000096943-25-000138.md) | [1,938](/filings/0000096943-26-000095.md) | [1,860](/filings/0000096943-26-000050.md) | [1,876](/filings/0000096943-26-000095.md) | | Total assets | $m | [7,494](/filings/0000096943-23-000102.md) | [7,533](/filings/0000096943-25-000031.md) | [7,478](/filings/0000096943-24-000072.md) | [7,442](/filings/0000096943-24-000132.md) | [7,486](/filings/0000096943-24-000148.md) | [7,098](/filings/0000096943-26-000019.md) | [7,163](/filings/0000096943-25-000077.md) | [7,375](/filings/0000096943-25-000115.md) | [7,872](/filings/0000096943-25-000138.md) | [6,947](/filings/0000096943-26-000095.md) | [6,783](/filings/0000096943-26-000050.md) | [6,787](/filings/0000096943-26-000095.md) | | Current liabilities | $m | [585](/filings/0000096943-23-000102.md) | [607](/filings/0000096943-25-000031.md) | [571](/filings/0000096943-24-000072.md) | [557](/filings/0000096943-24-000132.md) | [619](/filings/0000096943-24-000148.md) | [649](/filings/0000096943-26-000019.md) | [676](/filings/0000096943-25-000077.md) | [716](/filings/0000096943-25-000115.md) | [773](/filings/0000096943-25-000138.md) | [762](/filings/0000096943-26-000095.md) | [728](/filings/0000096943-26-000050.md) | [720](/filings/0000096943-26-000095.md) | | Total liabilities | $m | [3,180](/filings/0000096943-23-000102.md) | [3,092](/filings/0000096943-25-000031.md) | [2,975](/filings/0000096943-24-000072.md) | [2,883](/filings/0000096943-24-000132.md) | [3,005](/filings/0000096943-24-000148.md) | [2,820](/filings/0000096943-26-000019.md) | [3,068](/filings/0000096943-25-000077.md) | [3,132](/filings/0000096943-25-000115.md) | [4,050](/filings/0000096943-25-000138.md) | [3,822](/filings/0000096943-26-000095.md) | [3,699](/filings/0000096943-26-000050.md) | [3,882](/filings/0000096943-26-000095.md) | | Long-term debt | $m | [1,950](/filings/0000096943-23-000102.md) | [1,728](/filings/0000096943-25-000031.md) | [1,668](/filings/0000096943-24-000072.md) | [1,624](/filings/0000096943-24-000132.md) | [1,662](/filings/0000096943-24-000148.md) | [1,556](/filings/0000096943-26-000019.md) | [1,807](/filings/0000096943-25-000077.md) | [1,802](/filings/0000096943-25-000115.md) | [2,572](/filings/0000096943-25-000138.md) | [2,541](/filings/0000096943-26-000095.md) | [2,514](/filings/0000096943-26-000050.md) | [2,721](/filings/0000096943-26-000095.md) | | Current portion of debt | $m | [87.5](/filings/0000096943-23-000102.md) | [87.5](/filings/0000096943-25-000031.md) | [90.6](/filings/0000096943-24-000072.md) | [93.8](/filings/0000096943-24-000132.md) | [96.9](/filings/0000096943-24-000148.md) | [100](/filings/0000096943-26-000019.md) | [100](/filings/0000096943-25-000077.md) | [100](/filings/0000096943-25-000115.md) | [100](/filings/0000096943-25-000138.md) | [100](/filings/0000096943-26-000095.md) | [103](/filings/0000096943-26-000050.md) | [87.5](/filings/0000096943-26-000095.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [4,314](/filings/0000096943-24-000148.md) | [4,441](/filings/0000096943-26-000019.md) | [4,503](/filings/0000096943-25-000138.md) | [4,559](/filings/0000096943-25-000138.md) | [4,482](/filings/0000096943-25-000138.md) | [4,278](/filings/0000096943-26-000095.md) | [4,095](/filings/0000096943-26-000095.md) | [4,243](/filings/0000096943-26-000095.md) | [3,822](/filings/0000096943-25-000138.md) | [3,125](/filings/0000096943-26-000095.md) | [3,084](/filings/0000096943-26-000095.md) | [2,905](/filings/0000096943-26-000095.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [202 d](/filings/0000096943-24-000148.md) | [(166) d](/filings/0000096943-26-000019.md) | [113](/filings/0000096943-25-000077.md) | [91.7 d](/filings/0000096943-25-000115.md) | [231 d](/filings/0000096943-25-000138.md) | [(134) d](/filings/0000096943-26-000019.md) | [27.7](/filings/0000096943-26-000050.md) | [(37.0) d](/filings/0000096943-26-000095.md) | [198 d](/filings/0000096943-25-000138.md) | [(92.3) d](/filings/0000096943-26-000019.md) | [46.7](/filings/0000096943-26-000050.md) | [91.9 d](/filings/0000096943-26-000095.md) | | Capital expenditure | $m | [24.4 d](/filings/0000096943-24-000148.md) | [(17.3) d](/filings/0000096943-26-000019.md) | [38.4](/filings/0000096943-25-000077.md) | [34.8 d](/filings/0000096943-25-000115.md) | [21.2 d](/filings/0000096943-25-000138.md) | [(4.0) d](/filings/0000096943-26-000019.md) | [24.1](/filings/0000096943-26-000050.md) | [27.8 d](/filings/0000096943-26-000095.md) | [42.7 d](/filings/0000096943-25-000138.md) | [0.7 d](/filings/0000096943-26-000019.md) | [18.8](/filings/0000096943-26-000050.md) | [14.0 d](/filings/0000096943-26-000095.md) | | Dividends paid | $m | [16.0 d](/filings/0000096943-24-000148.md) | [16.0 d](/filings/0000096943-26-000019.md) | [16.0](/filings/0000096943-25-000077.md) | [16.0 d](/filings/0000096943-25-000115.md) | [15.8 d](/filings/0000096943-25-000138.md) | [15.7 d](/filings/0000096943-26-000019.md) | [15.2](/filings/0000096943-26-000050.md) | [15.0 d](/filings/0000096943-26-000095.md) | [15.0 d](/filings/0000096943-25-000138.md) | [15.0 d](/filings/0000096943-26-000019.md) | [15.1](/filings/0000096943-26-000050.md) | [14.8 d](/filings/0000096943-26-000095.md) | | Share repurchases | $m | not reported | [0.0 d](/filings/0000096943-26-000019.md) | [0.0](/filings/0000096943-25-000077.md) | [0.0 d](/filings/0000096943-25-000115.md) | [200 d](/filings/0000096943-25-000138.md) | [0.0 d](/filings/0000096943-26-000019.md) | [300](/filings/0000096943-26-000050.md) | [0.0 d](/filings/0000096943-26-000095.md) | [0.0 d](/filings/0000096943-25-000138.md) | [0.0 d](/filings/0000096943-26-000019.md) | [0.0](/filings/0000096943-26-000050.md) | [250 d](/filings/0000096943-26-000095.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [47.3](/filings/0000096943-23-000102.md) | [47.3](/filings/0000096943-24-000072.md) | [47.3](/filings/0000096943-24-000132.md) | [47.3](/filings/0000096943-24-000148.md) | [47.4](/filings/0000096943-25-000077.md) | [47.4](/filings/0000096943-25-000115.md) | [47.0](/filings/0000096943-25-000138.md) | [45.9](/filings/0000096943-26-000050.md) | [44.3](/filings/0000096943-26-000095.md) | [44.2](/filings/0000096943-25-000138.md) | [44.3](/filings/0000096943-26-000050.md) | [43.7](/filings/0000096943-26-000095.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 42,372,397 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0000096943-26-000095.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.